Skip to content
Clinical Trials – home

Centre Hospitalier Et Universitaire De Limoges

Verifiedinfo

France 2 Avenue Martin Luther King, 87000 Limoges, France

  • 204 trials recruiting
  • Plasma cell myeloma · Non-small cell lung cancer · Acute myeloid leukaemia
  • Adults and children

About Specializations

Centre Hospitalier Et Universitaire De Limoges in Limoges, France specialises in clinical trials of conditions such as Plasma cell myeloma, Non-small cell lung cancer, Acute myeloid leukaemia, Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms Research

The clinical trial activity at Centre Hospitalier Et Universitaire De Limoges focuses on oncology, with a strong emphasis on lung cancer care within the thoracic oncology unit. The studies are centered on improving treatment options for extensive stage small cell lung cancer, a fast-growing and difficult-to-treat disease.

  • Evaluating new treatment approaches for extensive stage small cell lung cancer
  • Comparing combination therapy with standard care to better understand overall survival benefits
  • Advancing thoracic oncology research for patients with advanced lung cancer

Overall, the research here is aimed at testing whether new cancer therapies can improve survival and provide better outcomes for people with advanced neoplasms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
2 Avenue Martin Luther King87000 LimogesFrance
Recruiting now
204 trials
Conditions studied
220
Partner status
Verified

More sites in LimogesFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

432 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:USNOFLAST
  • Sponsor:Zydus Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Carboplatin
  • Sponsor:Innate Pharma
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bio89-100
  • Sponsor:89bio Inc.

Hepatic fibrosis+2

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.